17Dec
14Dec
US winemakers revive sales with SMS marketing, sustainability and innovation
Bring the Wine to the People - As prices of bottles and tasting fees rise across wine country—but especially in premium regions like Napa Valley—winemakers are finding ways to offset declining sales and visits by bringing their wares to their most likely customers. There is nothing better than popping a cork to celebrate a major achievement or momentous occasion. But for younger drinkers who may only want one serving of alcohol, and are looking for something with a lighter carbon...
12Dec
Archer Roose Wines’ Rapid On-Premise Growth Continues, Inking National Distribution at Six New Restaurant and Hospitality Chains
Archer Roose, leading canned wine brand, is stacking up new wins in restaurant and hospitality properties around the country. Beginning now through January 2025, Archer Roose Wines will be placed across Levy Hospitality-served stadiums, arenas and venues, Atrium Hospitality-managed hotels, Vail Resort Group locations, STK Steakhouse and Kona Grill to-go menus, Old Chicago restaurants and Punch Bowl Social entertainment spaces. The new distribution deals come on the heels of recently-forged Archer Roose Wines placements at more than 150 Dave &...
12Dec
RevBio Receives Both FDA Approval to Expand its Clinical Trial and CMS Reimbursement for its Regenerative Bone Adhesive for Cranial Flap Fixation
RevBio, Inc., announced that it has received FDA approval to expand its ongoing clinical trial to immediately fixate cranial flaps using TETRANITE®, the company’s bone adhesive biomaterial. The company also received reimbursement coverage from the Centers for Medicare and Medicaid (“CMS”) for the use of TETRANITE to replace metal plates and screws. Previously, RevBio received FDA approval to initiate a first-in-human clinical study for an initial five patients to restore cranial flaps following craniotomy procedures and to repair extradural use...
10Dec
Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors
Corbus Pharmaceuticals Holdings, Inc., an oncology and obesity company with a diversified portfolio, today announced the dosing of the first patient in the Phase 1 portion of the clinical study of CRB-601 for the treatment of patients with advanced solid tumors (NCT06603844). CRB-601 is a monoclonal antibody targeting latent TGFβ activation-by blocking the integrin αVβ8. Pre-clinical data has demonstrated that CRB-601 overcomes tumor immune exclusion and enhances the activity of immune checkpoint inhibitors in vivo. Read more >>
05Dec
Buffalo Next: CleanFiber secures $20M in federal funds to help expand nationally
With $20 million in grants secured from the U.S. Department of Energy, CleanFiber is opening new plants in Washington and Texas. These grants are part of more than $75 million in financing vehicles, grants, and tax credits the Buffalo-headquartered startup has secured in 2024. The company, which makes building insulation from recycled corrugated cardboard supporting energy efficiency, moved to Buffalo after winning $500,000 in the 43North business competition in 2016. The company was founded in Massachusetts in 2013 and was...
29Nov
Purdue University and Akston Biosciences Bring “First Dose of Hope” in New Cancer Immunotherapy Trial for Dogs with Urinary Bladder Cancer
Purdue University and its College of Veterinary Medicine, in partnership with Akston Biosciences Corporation, has initiated the enrollment of dogs with urinary bladder cancer in a clinical trial of a pioneering immunotherapy. The immunotherapy consisting of an anti-cPD-L1 monoclonal antibody (mAb) is designed to target and block the cPD-L1 protein on cancer cells. This, in turn, is expected to enhance the immune system's ability to attack the cancer cells more effectively to improve outcomes and extend life. The strategic partnership...
15Nov
Arcitecta Partners with Wasabi Technologies to Offer Seamless Integration of Wasabi Cloud Storage into Data Workflows via a Single Unified View
Arcitecta, a creative and innovative data management software company, today announced it has partnered with Wasabi Technologies, the hot cloud storage company, enabling organizations to seamlessly and transparently integrate Wasabi’s cloud storage into their workflows. Arcitecta’s flagship product, Mediaflux®, acts as a gateway, allowing users to access Wasabi cloud storage and all their data regardless of where it resides through one unified view to drive informed decision-making, greater insights and business value. While integrating cloud storage into an organization’s workflow...
15Nov
New Vice President of Channel Sales at Aircuity
Jay Kress has been named vice president of channel sales at Aircuity, which provides airflow optimization technology. Kress brings a wealth of experience in sales leadership and strategic partnerships that will help the company’s network of channel partners continue to grow in the market, a press release from Aircuity said. Kress has a proven track record of driving results through collaborative, innovative approaches, and will be instrumental in supporting and expanding relationships, the company said. In his new role, Kress...
14Nov